triamterene 37.5 MG
RxNorm concept 316853, clinical drug component (scdc).
- RxCUI
- 316853
- Term type
- Clinical drug component (SCDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/316853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Related concepts
- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet [Maxzide] (SBD, constitutes)
- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule (SCD, constitutes)
- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Capsule [Dyazide] (SBD, constitutes)
- hydrochlorothiazide 25 MG / triamterene 37.5 MG Oral Tablet (SCD, constitutes)
- triamterene (IN, has ingredient)
- hydrochlorothiazide 25 MG / triamterene 37.5 MG [Maxzide] (SBDC, has tradename)
- hydrochlorothiazide 25 MG / triamterene 37.5 MG [Dyazide] (SBDC, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 316853 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/316853 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 316853. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.